Skin autofluorescence as proxy of tissue AGE accumulation is dissociated from SCORE cardiovascular risk score, and remains so after 3 years

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 1, 2014, Pages 121-127

  Tiessen, Ans H ^a   Jager, Willemein ^a   Bogt, Nancy C W Ter ^a   Beltman, Frank W ^a   Van Der Meer, Klaas ^a   Broer, Jan ^b   Smit, Andries J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Municipal Health Service   (Netherlands)

Author keywords

cardiovascular; SCORE risk estimation; skin autofluorescence

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

ADULT; AGED; ARTICLE; AUTOFLUORESCENCE; BIOACCUMULATION; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SKIN; SKIN AUTOFLUORESCENCE;

ADULT; AGE FACTORS; AGED; ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPERTENSION; LIFE STYLE; MALE; MIDDLE AGED; RISK FACTORS; SKIN; TIME FACTORS;

EID: 84891381498     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0825     Document Type: Article

References (30)

1. Meerwaldt R, Graaff R, Oomen PH, Links TP, Jager JJ, Alderson NL, et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004;47:1324-30.
2. Meerwaldt R, Graaff R, Huisman RJ, Links TP, Thorpe SR, Baynes JW, et al. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation endproducts, predicts mortality in hemodialysis patients. J Am Soc Nephrol 2005;16:3687-93.
3. den Hollander NC, Mulder DJ, Graaff R, Thorpe SR, Baynes JW, Smit GP, et al. Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia. J Inherit Metab Dis 2007;30:916-23.
4. Smit AJ, Gerrits EG. Skin autofluorescence as a measure of advanced glycation endproduct deposition: A novel risk marker in chronic kidney disease. Curr Opin Nephrol Hypertens 2010;19:527-33.
5. Januszewski AS, Sachithanandan N, Karschimkus C, O'Neal DN, Yeung CK, Alkatib N, et al. Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction. Diabet Med 2012;29:726-33.
6. Lutgers HL, Graaff G, Links TP, Ubink-Veltmaat LJ, Bilo HJ, Gans RO, et al. Non-invasive AGE-measurements by skin autofluorescence in patients with type 2 diabetes mellitus. Tool for risk-assessment of diabetic complications? Diabetes Care 2006;29:2654-9.
7. Meerwaldt R, Links TP, Graaff R, Hoogenberg K, Lefrandt JD, Baynes JW, et al. Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy. Diabetologia 2005;48:1637-44.
8. Gerrits EG, Lutgers HL, Kleefstra N, Graaff R, Groenier KH, Smit AJ, et al. Skin autofluorescence: A tool to identify type 2 diabetic patients at risk for developing microvascular complications. Diabetes Care 2008;31:517-21.
9. Lutgers HL, Gerrits EG, Graaff R, Links TP, Sluiter WJ, Gans RO, et al. Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus. Diabetologia 2009;52:789-97.
10. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-89.
11. Münch G, Westcott B, Menini T, Gugliucci A. Advanced glycation endproducts and their pathogenic roles in neurological disorders. Amino Acids 2012;42:1221-36.
12. Genuth S, Sun W, Cleary P, Sell DR, Dahms W, Malone J, et al. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes 2005;54:3103-11.
13. Chabroux S, Canouï-Poitrine F, Reffet S, Mills-Joncour G, Morelon E, Colin C, et al. Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy. Diabetes Metab 2010;36:152-7.
14. de Leeuw K, Graaff R, de Vries R, Dullaart RP, Smit AJ, Kallenberg CG, et al. Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus. Rheumatology 2007;46:1551-6.
15. McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW. Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3. Clin J Am Soc Nephrol 2011;6:2356-63.
16. Hartog JW, Gross S, Oterdoom LH, van Ree RM, de Vries AP, Smit AJ, et al. Skin-autofluorescence is an independent predictor of graft loss in renal transplant recipients. Transplantation 2009;87:1069-77.
17. Nienhuis HL, de Leeuw K, Bijzet J, Smit A, Schalkwijk CG, Graaff R, et al. Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts. Rheumatology (Oxford) 2008;47:1554-8.
18. de Leeuw K, Nienhuis H, Smit A, Stegeman C, Kallenberg C, Bijl M. Increased accumulation of advanced glycation endproducts in patients with Wegener's granulomatosis. Ann Rheum Dis 2010;69:625-7.
19. Matsumoto T, Tsurumoto T, Baba H, Osaki M, Enomoto H, Yonekura A, et al. Measurement of advanced glycation endproducts in skin of patients with rheumatoid arthritis, osteoarthritis, and dialysis-related spondyloarthropathy using non-invasive methods. Rheumatol Int 2007;28:157-60.
20. Mulder DJ, van Haelst PL, Gross S, de Leeuw K, Bijzet J, Graaff R, et al. Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products. Atherosclerosis 2007;197:217-23.
21. Mulder DJ, van Haelst PL, Graaff R, Gans RO, Zijlstra F, Smit AJ. Skin autofluorescence is elevated in acute myocardial infarction and is associated with the one-year incidence of major adverse cardiac events. Neth Heart J 2009;17:162-8.
22. Noordzij MJ, Lefrandt JD, Loeffen EA, Saleem BR, Meerwaldt R, Lutgers HL, et al. Skin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease. Int J Cardiovasc Imaging 2012;28:431-8.
23. de Vos LA, Noordzij MJ, Mulder DJ, Smit AJ, Lutgers HL, Dullaart RP, et al. Skin autofluorescence as a measure of advanced glycation end product deposition is elevated in peripheral artery disease. ATVB 2012. Available from: http://atvb.ahajournals.org/content/early/2012/11/08/ATVBAHA.112.300016. Accessed on November 27, 2012.
24. Lutgers HL, Graaff R, de Vries R, Smit AJ, Dullaart RP. Carotid artery intima media thickness associates with skin autofluoresence in non-diabetic subjects without clinically manifest cardiovascular disease. Eur J Clin Invest 2010;40:812-7.
25. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003.
26. ter Bogt NC, Bemelmans WJ, Beltman FW, Broer J, Smit AJ, van der Meer K. Preventing weight gain: one-year results of a randomized lifestyle intervention. Am J Prev Med 2009;37:270-7.
27. ter Bogt NC, Mulder IE, Bemelmans WJ, Beltman FW, Broer J, Smit AJ, et al. Changes in lifestyle habits after counselling by nurse practitioners: 1-year results of the Groningen Overweight and Lifestyle study. Public Health Nutr 2011; 14:995-1000.
28. ter Bogt NC, Bemelmans WJ, Beltman FW, Broer J, Smit AJ, van der Meer K. Preventing weight gain by lifestyle intervention in a general practice setting: three-year results of a randomized controlled trial. Arch Intern Med 2011;171:306-13.
29. Noordzij MJ, Mulder DJ, Oomen PH, Brouwer T, Jager J, Castro Cabezas M, et al. Skin autofluorescence and risk of micro-and macrovascular complications in patients with type 2 diabetes mellitus- A multi-centre study. Diabet Med 2012;29:1556-61.
30. Stolk RP, Rosmalen JG, Postma DS, de Boer RA, Navis G, Slaets JP, et al. Universal risk factors for multifactorial diseases: LifeLines: A three-generation population-based study. Eur J Epidemiol 2008;23:67-74.